Tata Digital, the subsidiary of Tata Sons, said on Thursday it is acquiring a majority stake in digital health startup 1mg, the latest in a series of investments as the salt-to-steel Indian conglomerate enters the digital consumer space.
The firms didn’t share the financial details of the deal, but earlier local media reports suggest that Tata Digital was planning to invest between $100 million to $110 million in the six-year-old Indian startup for 65% stake. A spokesperson for Tata Digital declined to comment. 1mg didn’t immediately respond to a request for comment.
According to insight firm Tracxn, 1mg had raised $156 million prior to Thursday’s announcement and was last valued at $242 million. This would suggest that Tata Digital is buying 1mg, which counts Bill & Melinda Gates Foundation and Sequoia Capital India among its investors, at a discount.
1mg is one of the largest players in the health space in India, where it competes with Prosus Ventures-backed PharmEasy, which leads the market. 1mg operates diagnostics labs, has a supply chain that covers over 20,000 Indian zipcodes, and is a major business-to-business distributor of medicines in the South Asian nation.
Tata Digital said its investment in 1mg is in line with the giant’s “vision of creating a digital ecosystem which addresses the consumer needs across categories in a unified manner.” The giant, which announced plans to invest in fitness startup CureFit earlier this week, acquired a majority stake in online grocer BigBasket earlier this year.
“We are delighted to join hands with one of India’s most iconic and respected conglomerates,” said Prashant Tandon, co-founder and chief executive of 1mg, in a statement. “This marks a significant milestone in 1mg’s journey to make high quality healthcare products and services accessible to customers across India.”
This is a developing story. More to follow…
